Cargando…
Mobility assessment using wearable technology in patients with late-onset Pompe disease
Late-onset Pompe disease (LOPD) is a rare genetic disorder due to the absence or deficiency of acid alpha-glucosidase enzyme resulting in slowly progressing reduction of muscle strength, causing difficulties with mobility and respiration. Wearable technologies offer novel options to evaluate mobilit...
Autores principales: | Hamed, Alaa, Curran, Christopher, Gwaltney, Chad, DasMahapatra, Pronabesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646308/ https://www.ncbi.nlm.nih.gov/pubmed/31341956 http://dx.doi.org/10.1038/s41746-019-0143-8 |
Ejemplares similares
-
Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease
por: Hamed, Alaa, et al.
Publicado: (2021) -
Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study
por: Dimachkie, Mazen M., et al.
Publicado: (2023) -
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
por: Hamed, Alaa, et al.
Publicado: (2021) -
Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective
por: Hamed, Alaa, et al.
Publicado: (2021) -
Patient-centered activity monitoring in the self-management of chronic health conditions
por: Chiauzzi, Emil, et al.
Publicado: (2015)